Antipsychotic News and Research

RSS
Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.
Antipsychotic use linked to reduced patient violence

Antipsychotic use linked to reduced patient violence

Salk scientists explore earliest detectable changes in the brain that lead to schizophrenia

Salk scientists explore earliest detectable changes in the brain that lead to schizophrenia

Antipsychotic medication can reduce violent crime among people with psychiatric illness

Antipsychotic medication can reduce violent crime among people with psychiatric illness

Antipsychotic medication reduces violent crime rates

Antipsychotic medication reduces violent crime rates

First Edition: May 8, 2014

First Edition: May 8, 2014

Psychiatrist wins Kempf Fund Award for Research Development in Psychobiological Psychiatry

Psychiatrist wins Kempf Fund Award for Research Development in Psychobiological Psychiatry

Antipsychotic response faster than thought

Antipsychotic response faster than thought

Alkermes reports financial results for first quarter of 2014

Alkermes reports financial results for first quarter of 2014

New approach may help reduce use of antipsychotics and other psychiatric drugs in dementia patients

New approach may help reduce use of antipsychotics and other psychiatric drugs in dementia patients

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Johnson & Johnson's sales increase 3.5% to $18.1 billion in first quarter 2014

Residential aged care facilities need to tackle antipsychotic usage in dementia patients

Residential aged care facilities need to tackle antipsychotic usage in dementia patients

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Geographical variation in antipsychotic efficacy not ruled out

Geographical variation in antipsychotic efficacy not ruled out

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

Forest Laboratories, Richter report positive results from cariprazine Phase IIb trial for bipolar depression

State highlights: Ark. court reverses $1.2B Medicaid drug judgment; Fla. officials overhauling child welfare agency

State highlights: Ark. court reverses $1.2B Medicaid drug judgment; Fla. officials overhauling child welfare agency

First Edition: March 21, 2014

First Edition: March 21, 2014

Primary negative symptoms worsen functioning in schizophrenia

Primary negative symptoms worsen functioning in schizophrenia

EEG-based biomarker can help predict psychotic disorder in high-risk individuals

EEG-based biomarker can help predict psychotic disorder in high-risk individuals

Suicidal behaviour in schizophrenia may herald future violence

Suicidal behaviour in schizophrenia may herald future violence

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

Innovative study uses pharmacogenomic test to treat patients with psychotic disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.